Cargando…
Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
Neuroblastoma (NB) is the most common extracranial solid tumor in children and, in the high-risk group, has a 5-year mortality rate of ~50%. The high mortality rate and significant treatment-related morbidities associated with current standard of care therapies belie the critical need for more toler...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225357/ https://www.ncbi.nlm.nih.gov/pubmed/32457760 http://dx.doi.org/10.3389/fimmu.2020.00873 |